Certified by Founder Lodge
Epidarex Capital
United States - Bethesda, Maryland
INVESTOR
1 Disclosed Funding Rounds $0
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets. Epidarex funds ground-breaking
| Company | Date | Round | Raised |
|---|---|---|---|
Mironid® Limited |
September, 14 ,2023 | Series A | |
Curve Therapeutics |
February, 28 ,2024 | Series A | $51,183,495 |
Epsilogen Ltd |
September, 10 ,2024 | Series B | $16,370,899 |
Mironid® Limited
Curve Therapeutics
Epsilogen Ltd
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)